Home β€Ί Stock analysis β€Ί NVS

Novartis Ag (NVS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

NVS ends flat (+0.2%) to $150.62, a 1-month high, 3 up days in a row. Closed at $150.62, +0.16% vs the prior close of $150.38. Day range $150.23–$151.74, opened at $150.65.

Last close$150.62+0.16%
Day range150.23–151.74
Open150.65
Volume1.73M
52-week range121.57–170.46
Avg volume (20d)1.81M

NVS daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” NVS ends flat (+0.2%) to $150.62, a 1-month high, 3 up days in a row
Oct 15, 2026 β€” NVS rises 2.4% to $150.38, a 1-month high
Oct 14, 2026 β€” NVS jumps 3.1% to $146.88
Oct 13, 2026 β€” NVS dips 1.0% to $142.41
Oct 12, 2026 β€” NVS ends flat (+0.1%) to $143.84
Oct 9, 2026 β€” NVS rises 0.4% to $143.75
Oct 8, 2026 β€” NVS ends flat (-0.1%) to $143.11
Oct 7, 2026 β€” NVS rises 1.8% to $143.28
Oct 6, 2026 β€” NVS ends flat (-0.1%) to $140.79, 6 down days in a row
Oct 5, 2026 β€” NVS ends flat (-0.0%) to $140.93, 5 down days in a row
Oct 2, 2026 β€” NVS ends flat (-0.0%) to $141.00, 4 down days in a row

NVS latest news & SEC filings

Every SEC filing by or about NVS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 8, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005908

Sep 4, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005896

Sep 1, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005824

Jul 21, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001114448-26-000012

Things to know before you trade NVS

NVS market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 2026150.65151.74150.23150.621.73M
Oct 15, 2026150.32151.83149.64150.382.09M
Oct 14, 2026144.35147.16144.17146.881.65M
Oct 13, 2026145.18145.24142.31142.411.84M
Oct 12, 2026143.84144.02143.12143.841.15M
Oct 9, 2026142.92143.96142.80143.751.90M
Oct 8, 2026142.77143.29140.68143.111.53M
Oct 7, 2026143.12144.28142.55143.281.85M
Oct 6, 2026141.32141.39139.67140.791.57M
Oct 5, 2026141.02141.02139.31140.931.33M
Oct 2, 2026141.46141.57139.95141.002.25M
Oct 1, 2026142.22142.50140.87141.052.06M
Sep 30, 2026145.39145.50142.56142.573.06M
Sep 29, 2026144.81146.18144.46145.711.60M
Sep 28, 2026145.77147.03145.72146.881.95M
Sep 25, 2026144.57145.51144.00145.461.17M
Sep 24, 2026143.00144.66142.91143.571.89M
Sep 23, 2026143.15143.94142.03142.712.52M
Sep 22, 2026141.26141.80140.00141.281.54M
Sep 21, 2026141.96142.18140.96140.981.55M

About Novartis Ag

Novartis Ag (NVS) is listed on the NYSE and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in BASEL, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1114448.

NVS board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

NVS financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

NVS earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on NVS

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.